Essential Healthcare News
SEE OTHER BRANDS

Global take on healthcare and wellness news

Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on May 5, 2025

Proposed 2025 HIPAA Updates: How Employers Could Be Affected

Proposed 2025 HIPAA Updates: How Employers Could Be Affected

RENO, NV, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- As mentioned at the beginning of January by The HIPAA Journal, HIPAA (Health Insurance Portability and Accountability Act) has proposed long-awaited policy updates focused on its "Security Rule." …

Too Much Screen Time - New Study Links Specific Types of Tech Use to Worse Mental Health in Youth

Too Much Screen Time - New Study Links Specific Types of Tech Use to Worse Mental Health in Youth

Youth with elevated screen time had more severe symptoms—93% reduced their usage and improved outcomes during care with Bend Health MADISON, WI, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Excessive screen time may be doing more than just replacing …

Atticus Pharma Announces Upcoming Late-Breaking Presentation of Collaborative Research at the 82nd Annual SID 2025

Atticus Pharma Announces Upcoming Late-Breaking Presentation of Collaborative Research at the 82nd Annual SID 2025

GREENVILLE, SC, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Atticus Pharma Inc, a therapeutics company focused on immunodermatology and associated conditions, today announced the presentation of pre-clinical results in a novel murine model of …

 Dr. Danay Rodriguez-Arritola Honored with 2025 Visionary Leader by Florida Nurses Association South Region

Dr. Danay Rodriguez-Arritola Honored with 2025 Visionary Leader by Florida Nurses Association South Region

Chief Nursing Officer Award by Florida Nurses Association South Region MIAMI, FL, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Dr. Danay Rodriguez-Arritola, Chief Nursing Officer at Larkin Community Hospital’s Palm Springs Campus, has been named the …

UbiVac Presents 1st Report of In Vivo Generated T Cell Receptor (TCR) to Dark Genome-Derived Cancer’s Dark Matter

UbiVac Presents 1st Report of In Vivo Generated T Cell Receptor (TCR) to Dark Genome-Derived Cancer’s Dark Matter

UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity HONOLULU, HI, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- UbiVac, www.ubivac.com, a …

Dr. Kevin Sadati Presented His Facelift Technique at Prestigious New York Master Course on Facial Rejuvenation

Dr. Kevin Sadati Presented His Facelift Technique at Prestigious New York Master Course on Facial Rejuvenation

At the intersection of science and artistry, facial plastic surgery continues to evolve—and Dr. Kevin Sadati, is pushing the boundaries yet again. NEWPORT BEACH, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- At the intersection of science and …

R&L Spring Company Opens 3rd Location to Support Expanded Growth

R&L Spring Company Opens 3rd Location to Support Expanded Growth

Elkhorn, WI location expands operational capacity by 50,000 square feet, and allows for planned future growth. LAKE GENEVA, WI, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- LAKE GENEVA, WI (May 5, 2025) R…

Vintage Park Lands Experiential Wellness Studio Featuring Float Therapy, Cold Plunge, Sauna, Red Light & More

Vintage Park Lands Experiential Wellness Studio Featuring Float Therapy, Cold Plunge, Sauna, Red Light & More

Immersive wellness is coming to Vintage Park—featuring float therapy, cold plunge, sauna, red light, and more to help you reset, recover, and recharge. HOUSTON, TX, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Altered States Wellness, a Dallas-based …

Biomed Industries, Inc.  to Present Phase 2 Results on NA-931—An Oral Alternative to Injectables for Obesity—at ADA 2025

Biomed Industries, Inc. to Present Phase 2 Results on NA-931—An Oral Alternative to Injectables for Obesity—at ADA 2025

Biomed Industries, Inc. to Present Phase 2 Results on NA-931—An Oral Medicine Alternative to Injectables for Obesity—at ADA Conference 2025 in Chicago SAN JOSE, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Biomed Industries, Inc. (“Biomed”) …

Virtual Front Desk Solution Provider WelcomeWare® Now A PTPN Preferred Vendor

Virtual Front Desk Solution Provider WelcomeWare® Now A PTPN Preferred Vendor

Virtual front desk solution provider WelcomeWare® is pleased to announce that it has become a Preferred Vendor of Physical Therapy Provider Network (PTPN) GREENWICH, CT, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Virtual front desk solution …

AgileOne Recognized as Top Global MSP Provider by HRO Today

AgileOne Recognized as Top Global MSP Provider by HRO Today

AgileOne is honored to share that the company has been selected as the top global Managed Service Provider (MSP) by HRO Today. TORRANCE, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- AgileOne is honored to share that the company has been selected …

Global Safety Leaders Convene in Riyadh for Record-Breaking Occupational Safety and Health Conference

Global Safety Leaders Convene in Riyadh for Record-Breaking Occupational Safety and Health Conference

Largest, most international edition to date and one of the leading occupational safety and health conferences RIYADH, SAUDI ARABIA, May 5, 2025 /⁨EINPresswire.com⁩/ -- High-profile international event gathers global leaders in occupational safety and …

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has …

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8: …

JBDI Holdings Limited Announces US$1.0 Million Share Repurchase Program

JBDI Holdings Limited Announces US$1.0 Million Share Repurchase Program

Singapore, May 05, 2025 (GLOBE NEWSWIRE) -- (“JBDI” or the “Company”) (NASDAQ: JBDI) today announced that its board of directors (the “Board”) has approved a share repurchase program (the “Share Repurchase Program”). Pursuant to the Share Repurchase …

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the …

DBV Technologies participera à la conférence Citizens JMP Life Sciences

DBV Technologies participera à la conférence Citizens JMP Life Sciences

Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June Initial Phase 2 data for rosnilimab in …

Certara Reports First Quarter 2025 Financial Results

Certara Reports First Quarter 2025 Financial Results

RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 …

Context Therapeutics Announces Chief Medical Officer Transition

Context Therapeutics Announces Chief Medical Officer Transition

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service